PA Volberding - Annals of internal medicine, 2005 - Am Coll Physicians Recently, a case of HIV infection in New York City gained wide public attention because of the
possibility that it represented a novel and "superaggressive" virus, capable of causing rapid clinical
disease and broadly resistant to available drugs (1). Publicizing this case before careful ... Related articles - All 4 versions
SM Smith - Retrovirology, 2005 - biomedcentral.com On February 11, 2005, New York City (NYC) health officials announced the discovery of a "rare
strain of multi-drug resistant HIV that rapidly progresses to AIDS." According to the NYC Department
of Health and Mental Hygiene, a man in his mid-40s was diagnosed with HIV infection in ... Cited by 5 - Related articles - Cached - All 10 versions
- ►cdc.gov C Investigation - medscape.com In December 2004, infection with a strain of multidrug-resistant (MDR), dual-tropic* human immunodeficiency
virus (HIV)-1 was newly diagnosed in a man aged 46 years in New York City (NYC). The man
(ie, the index patient) had no history of antiretroviral treatment and reported having sex ... Related articles - All 5 versions
MTOBE LEARNED - CLEVELAND CLINIC JOURNAL OF MEDICINE, 2005 - ccjm.org ECENTLY, the New York City Department of Health and Mental Hygiene reported detecting a
rapidly progressive, highly resistant strain of human immunodeficiency virus (HIV).1 The
virus, dubbed “three-drug-class resistant” (3-DCR) because it is resistant to three of the ... Related articles - All 2 versions
GH Friedland - AIDS Clinical Care, 2005 - medscape.com The general background of the case has already been reported. Succinctly, the patient is an
MSM in his late 40s. After developing illness consistent with acute retroviral syndrome in November
2004, he tested HIV-positive in mid-December. Later that month, his CD4 count was 80 ... Related articles - All 3 versions
C Hicks, C Pilcher, J Eron, A Weintrob, J … - … and abstracts of the …, 2004 - retroconference.org ABSTRACT Background: Antiretroviral resistance transmitted to newly infected patients impairs
efficacy of HAART. Transmitted resistance implies source patients are receiving incompletely
suppressive antiretroviral therapy. Studies in urban populations indicate increasing rates ... Cited by 9 - Related articles - View as HTML
